Cannell & Co. Cerus Corp Transaction History
Cannell & Co.
- $3.01 Billion
- Q4 2023
Shares
2 transactions
Others Institutions Holding CERS
# of Institutions
156Shares Held
147MCall Options Held
84.2KPut Options Held
55.5K-
Baker Bros. Advisors LP New York, NY19.5MShares$32.3 Million0.36% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.2MShares$30.3 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$23.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$18 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.54MShares$14.2 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $294M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...